Estrella Immunopharma, Inc.: Form 8-K, filed Jan 13, 2026
Filed with the SEC on Jan 13, 2026 and accepted by EDGAR at Jan 13, 2026, 17:21 ET.
Items reported
- Item 3.01 Delisting notice
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-26-003998. Last ingested by Listed: Nov 4, 2026, 07:37 ET. Listed shows no prices and gives no investment advice.